FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 2220373 · Received August 23, 2011

Report

Report Number
1030489-2011-01085
Event Type
Injury
Date Received
August 23, 2011
Report Date
July 28, 2011
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

(B)(4): NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. A REVIEW OF THE CERTIFICATES OF ANALYSIS AND PACKING LIST FOR THE INFUSE BONE GRAFT DID NOT REVEAL ANY NON-CONFORMANCES TO SPECIFICATION WHICH MIGHT CONTRIBUTE TO THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT AN EXPLORATION OF FUSION WITH REMOVAL OF POSTERIOR SEGMENTAL INSTRUMENTATION AND L5-S1 LAMINECTOMY WITH REFUSION USING RHBMP-2/ACS. THE PATIENT WAS DISCHARGED TO A SKILLED NURSING FACILITY. THE PATIENT RETURNED TO THE HOSPITAL SEVEN DAYS AFTER DISCHARGE WITH A FEVER UP TO 103 ASSOCIATED WITH CHILLS AND RIGOR DURING THE PREVIOUS TWO DAYS. UPON RE-ADMISSION TO THE HOSPITAL, BLOOD WAS COLLECTED FOR CULTURE AND TESTED POSITIVE FOR (B)(6). FIVE DAYS LATER, A LUMBAR INCISION WAS MADE AND DRAINAGE FOR CULTURE WAS COLLECTED AND TESTED POSITIVE FOR (B)(6). INCREASED LOWER BACK PAIN AND A MILD HEADACHE WITH DRAINAGE FROM THE INCISION SITE WAS NOTED. THE PATIENT WAS DISCHARGED 6 DAYS AFTER THE PROCEDURE. PRIOR TO DISCHARGE, THE PATIENT WAS GIVEN A COURSE OF ANTIBIOTICS. NO ADDITIONAL COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA M111054AAF

Patients

Seq Age Sex Outcome Treatment
1 00058 YR Required Intervention